Naylor, M., J. Karlawish, S. Arnold, A. Khachaturian, Z. Khachaturian, V. Lee, M. Baumgart, S. Banerjee, C. Beck, K. Blennow, R. Brookmeyer, K. Brunden, K. Buckwalter, M. Comer, K. Covinsky, L. Feinberg, G. Frisoni, C. Green, R. Guimaraes, L. Gwyther, F. Hefti, M. Hutton, C. Kawas, D. Kent, L. Kuller, K. Langa, R. Mahley, K. Maslow, C. Masters, D. Meier, P. Neumann, S. Paul, R. Petersen, M. Sager, M. Sano, D. Schenk, H. Soares, R. Sperling, S. Stahl, D. van, Y. Stern, D. Weir, D. Wolk, and J. Trojanowski. “Advancing Alzheimer’s Disease Diagnosis, Treatment, and Care: Recommendations from the Ware Invitational Summit.”. Alzheimer’s & Dementia : The Journal of the Alzheimer’s Association, Vol. 8, no. 5, 2012, pp. 445-52.
To address the pending public health crisis due to Alzheimer’s disease (AD) and related neurodegenerative disorders, the Marian S. Ware Alzheimer Program at the University of Pennsylvania held a meeting entitled “State of the Science Conference on the Advancement of Alzheimer’s Diagnosis, Treatment and Care,” on June 21-22, 2012. The meeting comprised four workgroups focusing on Biomarkers; Clinical Care and Health Services Research; Drug Development; and Health Economics, Policy, and Ethics. The workgroups shared, discussed, and compiled an integrated set of priorities, recommendations, and action plans, which are presented in this article.
DOI: 10.1016/j.jalz.2012.08.001
PubMed: 22959699